The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global API Contract Manufacturing Market Research Report 2025
Synopsis
Contract manufacturing is the process where manufacturer engages into an agreement with the companies for component or product manufacturing. Active pharmaceutical ingredient (API) contract manufacturing refers to the development of pharmaceutical drugs through contract manufacturing by outsourcing to other companies.
The global API Contract Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for API Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding API Contract Manufacturing.
Report Scope
The API Contract Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global API Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the API Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca Plc
BoehringerIngelhein GmbH
GlaxoSmithKline Pharmaceuticals Ltd
Merck＆Co.，Inc
Novartis AG
Piramal Pharma Solutions
Ranbaxy Laboratories Ltd.
Reddy's Laboratories Ltd
Sandoz-Lek-Biochemie
Sun Pharmaceutical Industries Ltd
Teva Pharmaceuticals Industries Ltd
Segment by Type
Commercial Manufacturing
Clinical Manufacturing
Segment by Application
Oncology
Central nervous system
Cardiovascular disorder
Infectious diseases
Pulmonary disorders
Metabolic disorder
Gastrointestinal disorders
Musculoskeletal disorders
Genitourinary disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of API Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Contract manufacturing is the process where manufacturer engages into an agreement with the companies for component or product manufacturing. Active pharmaceutical ingredient (API) contract manufacturing refers to the development of pharmaceutical drugs through contract manufacturing by outsourcing to other companies.
The global API Contract Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for API Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding API Contract Manufacturing.
Report Scope
The API Contract Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global API Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the API Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca Plc
BoehringerIngelhein GmbH
GlaxoSmithKline Pharmaceuticals Ltd
Merck＆Co.，Inc
Novartis AG
Piramal Pharma Solutions
Ranbaxy Laboratories Ltd.
Reddy's Laboratories Ltd
Sandoz-Lek-Biochemie
Sun Pharmaceutical Industries Ltd
Teva Pharmaceuticals Industries Ltd
Segment by Type
Commercial Manufacturing
Clinical Manufacturing
Segment by Application
Oncology
Central nervous system
Cardiovascular disorder
Infectious diseases
Pulmonary disorders
Metabolic disorder
Gastrointestinal disorders
Musculoskeletal disorders
Genitourinary disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of API Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global API Contract Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Commercial Manufacturing
1.2.3 Clinical Manufacturing
1.3 Market by Application
1.3.1 Global API Contract Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Central nervous system
1.3.4 Cardiovascular disorder
1.3.5 Infectious diseases
1.3.6 Pulmonary disorders
1.3.7 Metabolic disorder
1.3.8 Gastrointestinal disorders
1.3.9 Musculoskeletal disorders
1.3.10 Genitourinary disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global API Contract Manufacturing Market Perspective (2019-2030)
2.2 API Contract Manufacturing Growth Trends by Region
2.2.1 Global API Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 API Contract Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 API Contract Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 API Contract Manufacturing Market Dynamics
2.3.1 API Contract Manufacturing Industry Trends
2.3.2 API Contract Manufacturing Market Drivers
2.3.3 API Contract Manufacturing Market Challenges
2.3.4 API Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top API Contract Manufacturing Players by Revenue
3.1.1 Global Top API Contract Manufacturing Players by Revenue (2019-2024)
3.1.2 Global API Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global API Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by API Contract Manufacturing Revenue
3.4 Global API Contract Manufacturing Market Concentration Ratio
3.4.1 Global API Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by API Contract Manufacturing Revenue in 2023
3.5 API Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players API Contract Manufacturing Product Solution and Service
3.7 Date of Enter into API Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 API Contract Manufacturing Breakdown Data by Type
4.1 Global API Contract Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global API Contract Manufacturing Forecasted Market Size by Type (2025-2030)
5 API Contract Manufacturing Breakdown Data by Application
5.1 Global API Contract Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global API Contract Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America API Contract Manufacturing Market Size (2019-2030)
6.2 North America API Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America API Contract Manufacturing Market Size by Country (2019-2024)
6.4 North America API Contract Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe API Contract Manufacturing Market Size (2019-2030)
7.2 Europe API Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe API Contract Manufacturing Market Size by Country (2019-2024)
7.4 Europe API Contract Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific API Contract Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific API Contract Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific API Contract Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific API Contract Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America API Contract Manufacturing Market Size (2019-2030)
9.2 Latin America API Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America API Contract Manufacturing Market Size by Country (2019-2024)
9.4 Latin America API Contract Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa API Contract Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa API Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa API Contract Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa API Contract Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Detail
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc API Contract Manufacturing Introduction
11.1.4 AstraZeneca Plc Revenue in API Contract Manufacturing Business (2019-2024)
11.1.5 AstraZeneca Plc Recent Development
11.2 BoehringerIngelhein GmbH
11.2.1 BoehringerIngelhein GmbH Company Detail
11.2.2 BoehringerIngelhein GmbH Business Overview
11.2.3 BoehringerIngelhein GmbH API Contract Manufacturing Introduction
11.2.4 BoehringerIngelhein GmbH Revenue in API Contract Manufacturing Business (2019-2024)
11.2.5 BoehringerIngelhein GmbH Recent Development
11.3 GlaxoSmithKline Pharmaceuticals Ltd
11.3.1 GlaxoSmithKline Pharmaceuticals Ltd Company Detail
11.3.2 GlaxoSmithKline Pharmaceuticals Ltd Business Overview
11.3.3 GlaxoSmithKline Pharmaceuticals Ltd API Contract Manufacturing Introduction
11.3.4 GlaxoSmithKline Pharmaceuticals Ltd Revenue in API Contract Manufacturing Business (2019-2024)
11.3.5 GlaxoSmithKline Pharmaceuticals Ltd Recent Development
11.4 Merck＆Co.，Inc
11.4.1 Merck＆Co.，Inc Company Detail
11.4.2 Merck＆Co.，Inc Business Overview
11.4.3 Merck＆Co.，Inc API Contract Manufacturing Introduction
11.4.4 Merck＆Co.，Inc Revenue in API Contract Manufacturing Business (2019-2024)
11.4.5 Merck＆Co.，Inc Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Detail
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG API Contract Manufacturing Introduction
11.5.4 Novartis AG Revenue in API Contract Manufacturing Business (2019-2024)
11.5.5 Novartis AG Recent Development
11.6 Piramal Pharma Solutions
11.6.1 Piramal Pharma Solutions Company Detail
11.6.2 Piramal Pharma Solutions Business Overview
11.6.3 Piramal Pharma Solutions API Contract Manufacturing Introduction
11.6.4 Piramal Pharma Solutions Revenue in API Contract Manufacturing Business (2019-2024)
11.6.5 Piramal Pharma Solutions Recent Development
11.7 Ranbaxy Laboratories Ltd.
11.7.1 Ranbaxy Laboratories Ltd. Company Detail
11.7.2 Ranbaxy Laboratories Ltd. Business Overview
11.7.3 Ranbaxy Laboratories Ltd. API Contract Manufacturing Introduction
11.7.4 Ranbaxy Laboratories Ltd. Revenue in API Contract Manufacturing Business (2019-2024)
11.7.5 Ranbaxy Laboratories Ltd. Recent Development
11.8 Reddy's Laboratories Ltd
11.8.1 Reddy's Laboratories Ltd Company Detail
11.8.2 Reddy's Laboratories Ltd Business Overview
11.8.3 Reddy's Laboratories Ltd API Contract Manufacturing Introduction
11.8.4 Reddy's Laboratories Ltd Revenue in API Contract Manufacturing Business (2019-2024)
11.8.5 Reddy's Laboratories Ltd Recent Development
11.9 Sandoz-Lek-Biochemie
11.9.1 Sandoz-Lek-Biochemie Company Detail
11.9.2 Sandoz-Lek-Biochemie Business Overview
11.9.3 Sandoz-Lek-Biochemie API Contract Manufacturing Introduction
11.9.4 Sandoz-Lek-Biochemie Revenue in API Contract Manufacturing Business (2019-2024)
11.9.5 Sandoz-Lek-Biochemie Recent Development
11.10 Sun Pharmaceutical Industries Ltd
11.10.1 Sun Pharmaceutical Industries Ltd Company Detail
11.10.2 Sun Pharmaceutical Industries Ltd Business Overview
11.10.3 Sun Pharmaceutical Industries Ltd API Contract Manufacturing Introduction
11.10.4 Sun Pharmaceutical Industries Ltd Revenue in API Contract Manufacturing Business (2019-2024)
11.10.5 Sun Pharmaceutical Industries Ltd Recent Development
11.11 Teva Pharmaceuticals Industries Ltd
11.11.1 Teva Pharmaceuticals Industries Ltd Company Detail
11.11.2 Teva Pharmaceuticals Industries Ltd Business Overview
11.11.3 Teva Pharmaceuticals Industries Ltd API Contract Manufacturing Introduction
11.11.4 Teva Pharmaceuticals Industries Ltd Revenue in API Contract Manufacturing Business (2019-2024)
11.11.5 Teva Pharmaceuticals Industries Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
